References
- Jalanko A, Braulke T. Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 2009;1793:697–709
- Ostergaard JR, Rasmussen TB, Molgaard H. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology 2011;76:1245–1251
- Munroe PB, Mitchison HM, O’Rawe AM, et al. Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 1997;61:310–316
- Bozorg S, Ramirez-Montealegre D, Chung M, et al. Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye. Surv Ophthalmol 2009;54:463–471
- Ostergaard JR, Hertz JM. Juvenile neuronal ceroid lipofuscinosis. Ugeskr Laeger 1998;160:3895–3900
- Williams RE, Aberg L, Autti T, et al. Diagnosis of the neuronal ceroid lipofuscinoses: an update. Biochim Biophys Acta 2006;1762:865–872
- Bateman JB, Philippart M. Ocular features of the Hagberg-Santavuori syndrome. Am J Ophthalmol 1986;102:262–271
- Tinsa F, Caillaud C, Jallouli M, et al. Late infantile neuronal ceroid lipofuscinosis in a Tunisian Boy. Neuro-Ophthalmology 2008;32:210–213
- Nielsen AK, Ostergaard JR. Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience. Eur J Paediatr Neurol 2013;17:265–268
- Orlin A, Dolan S, Witmer MT, et al. Spectrum of ocular manifestations in CLN2-associated Batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function. PLoS One 2013;8:e73128
- Traboulsi EI, Green WR, Luckenbach MW, et al. Neuronal ceroid lipofuscinosis. Ocular histopathologic and electron microscopic studies in the late infantile, juvenile, and adult forms. Graefes Arch Clin Exp Ophthalmol 1987;225:391–402
- Bensaoula T, Shibuya H, Katz ML, et al. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease. Ophthalmology 2000;107:1746–1753
- Jackson H, Garway-Heath D, Rosen P, et al. Outcome of cataract surgery in patients with retinitis pigmentosa. Br J Ophthalmol 2001;85:936–938
- Fishman GA, Anderson RJ, Lourenco P, et al. Prevalence of posterior subcapsular lens opacities in patients with retinitis pigmentosa. Br J Ophthalmol 1985;69:263–266
- Yoshida N, Ikeda Y, Notomi S, et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 2013;120:100–105
- Whitcup SM, Nussenblatt RB, Lightman SL, et al. Inflammation in retinal disease. Int J Inflam 2013;ID 724648
- Drack AV, Mullins RF, Pfeifer WL, et al. Immunosuppressive treatment for retinal degeneration in juvenile neuronal ceroid lipofuscinosis (Juvenile Batten Disease). Ophthalmic Genet. 2014 (1–6) e-pub Feb 19
- Stunkel M, Bhattarai S, Kemerley A, et al. Vitritis in pediatric genetic retinal disorders. Ophthalmology [Epub ahead of print 9 Sept 2014]
- Handart J, Vinker S, Nemet A, et al. Prevalence of epilepsy among cataract patients. Curr Eye Res 2010;35:487–491
- Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs 2010;24:501–526